Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2019-12-04 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
关于参加独立董事培训并取得独立董事资格证书的承诺函（张继承）
Board/Management Information Classification · 95% confidence The document is a written commitment letter from an individual nominated as an independent director candidate, promising to attend training and obtain the required independent director qualification certificate as per Shenzhen Stock Exchange regulations. It is not a report, financial statement, or announcement of voting results, but rather a formal declaration related to board/management qualifications. This fits best under Board/Management Information (MANG) as it concerns board member qualifications and related commitments.
2019-12-04 Chinese
关于公司董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new board of directors for 康芝药业股份有限公司 (Kangzhi Pharmaceutical Co., Ltd.). It details the expiration of the current board's term, the nomination of candidates for the new board, their qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on board member changes and election procedures. Therefore, this document fits the category of Board/Management Information (MANG). The document length is about 4900 characters, which is consistent with a detailed announcement rather than a brief notice or report publication announcement.
2019-12-04 Chinese
海通证券股份有限公司关于公司继续使用闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from Haitong Securities, the sponsor institution, regarding Kangzhi Pharmaceutical's continued use of idle raised funds for cash management. It references regulatory guidelines and approvals, details the amount and usage of raised funds, investment products, risk control, and includes opinions from independent directors, the supervisory board, and the sponsor institution. The document is not a full annual or interim financial report, nor is it a brief announcement or a certification. It is a formal audit or verification opinion related to the use of raised funds, which fits the category of an Audit Report / Information (AR). The document length is 3655 characters, which is relatively short but contains substantive content and detailed analysis, not just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2019
2019-12-04 Chinese
关于召开2019年第一次临时股东大会通知的公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2019 first extraordinary general meeting of shareholders for 康芝药业股份有限公司. It includes information about the meeting date, location, voting procedures (including cumulative voting for board and supervisory board elections), registration details, and proxy forms. The content focuses on the organization and conduct of a shareholders' meeting, specifically the election of board members and supervisors. There are no financial statements, audit opinions, or earnings data presented. The document is not a report itself but a notice and instructions related to a shareholders meeting. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length (8029 characters) and detailed procedural content support this classification with high confidence.
2019-12-04 Chinese
关于使用自有闲置资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 康芝药业股份有限公司 regarding the use of its own idle funds for cash management by investing in low-risk financial products. It details the board meeting approval, investment purpose, amount, types, risk analysis, internal controls, and opinions from independent directors and the supervisory board. There are no financial statements or comprehensive financial data presented, nor is this a transcript, report, or presentation. The document is a formal announcement of a corporate decision related to capital management and investment activities. It fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage policies.
2019-12-04 Chinese
关于参加独立董事培训并取得独立董事资格证书的承诺函（陈思东）
Board/Management Information Classification · 95% confidence The document is a written commitment letter from an individual nominated as an independent director candidate, promising to attend training and obtain the required independent director qualification certificate as per Shenzhen Stock Exchange regulations. It is related to board/management information, specifically about a director candidate's qualifications and compliance with regulatory requirements. It is not a financial report, audit, or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is a formal declaration related to board membership qualifications.
2019-12-04 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.